Education
About Us
Working with TipRanks
Follow Us
FLGB - AI Analysis
Top Page
Franklin FTSE United Kingdom ETF (FLGB)
Rating:71Outperform
Price Target:
$36.48
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Rolls-Royce and HSBC Holdings, have shown strong year-to-date performance, contributing positively to the fund's returns.
Low Expense Ratio
The ETF has a very low expense ratio, making it a cost-effective option for investors.
Sector Diversification
The fund is spread across multiple sectors, including Financials, Consumer Defensive, and Industrials, which helps reduce risk from sector-specific downturns.
Negative Factors
Geographic Concentration
The ETF is heavily concentrated in the UK, with over 99% exposure, which limits diversification across global markets.
Low Technology Exposure
The fund has minimal exposure to the Technology sector, which could limit potential gains from high-growth industries.
Mixed Performance in Top Holdings
While some top holdings have performed well, others like Shell and Unilever have shown weaker year-to-date performance, which could weigh on overall returns.
FLGB vs. SPDR S&P 500 ETF (SPY)
AUM922.28M
RegionEurope
Expense Ratio0.09%
Beta0.56
IssuerFranklin
Inception DateNov 02, 2017
Dividend Yield3.35%
Asset ClassEquity
Index TrackedFTSE UK RIC Capped Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume443,683
30 Day Avg. Volume185,204
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
36.48Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering97
FLGB Summary
The Franklin FTSE United Kingdom ETF (FLGB) is an investment fund that tracks the FTSE UK RIC Capped Index, giving investors exposure to a wide range of companies in the UK market. It includes well-known names like AstraZeneca and HSBC Holdings, along with smaller firms, covering industries such as finance, healthcare, and energy. This ETF is a good choice for those looking to diversify their portfolio and benefit from the overall growth of the UK economy. However, new investors should be aware that its performance is closely tied to the UK market, which can fluctuate based on economic conditions.
How much will it cost me?The Franklin FTSE United Kingdom ETF (FLGB) has an expense ratio of 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?The Franklin FTSE United Kingdom ETF (FLGB) could benefit from positive trends in the UK economy, such as growth in the financial and healthcare sectors, which are heavily weighted in the fund. However, potential risks include economic uncertainty due to interest rate changes, energy price volatility affecting holdings like Shell and BP, and regulatory shifts impacting major industries like financials and consumer goods. Investors should also consider how broader European economic conditions might influence the ETF's performance.
FLGB Top 10 Holdings
The Franklin FTSE United Kingdom ETF showcases a strong tilt toward financials, consumer defensive, and industrial sectors, with AstraZeneca and HSBC leading the charge. AstraZeneca’s steady gains reflect its robust pipeline and strategic growth initiatives, while HSBC’s mixed performance highlights challenges in specific markets despite its profitability. Rolls-Royce is a standout, soaring on strategic progress, while British American Tobacco lags, weighed down by bearish technical indicators. With its focus on the UK market, the fund captures a diverse economic landscape, though its heavy sector concentration may amplify risks tied to regional trends.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AstraZeneca | 8.15% | $75.23M | £194.28B | 7.89% | 75 Outperform | |
| HSBC Holdings | 7.56% | $69.81M | £172.71B | 45.06% | 79 Outperform | |
| Shell (UK) | 7.21% | $66.60M | £164.24B | 12.56% | 77 Outperform | |
| Unilever | 4.88% | $45.02M | £114.97B | -2.93% | 77 Outperform | |
| Rolls-Royce Holdings | 4.11% | $37.99M | £94.31B | 104.11% | 71 Outperform | |
| British American Tobacco | 3.39% | $31.32M | £84.93B | 45.99% | 60 Neutral | |
| BP p.l.c. | 3.01% | $27.79M | £66.87B | 9.24% | 57 Neutral | |
| GlaxoSmithKline | 2.87% | $26.52M | £65.11B | 12.95% | 78 Outperform | |
| RELX plc | 2.80% | $25.82M | £63.79B | -2.66% | 79 Outperform | |
| National Grid | 2.46% | $22.75M | £57.11B | 14.56% | 71 Outperform |
FLGB Technical Analysis
Positive
―
Price Trends
32.20
Positive
31.49
Positive
29.74
Positive
Market Momentum
0.20
Negative
63.54
Neutral
93.48
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLGB, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.54, equal to the 50-day MA of 32.20, and equal to the 200-day MA of 29.74, indicating a bullish trend. The MACD of 0.20 indicates Negative momentum. The RSI at 63.54 is Neutral, neither overbought nor oversold. The STOCH value of 93.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLGB.
FLGB Peer Comparison
Comparison Results
Performance Comparison
FLGB
Franklin FTSE United Kingdom ETF
32.96
6.41
24.14%
EWU
iShares MSCI United Kingdom ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
FKU
First Trust United Kingdom AlphaDEX Fund
―
―
―
EWUS
iShares MSCI United Kingdom Small Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents